Cargando…

WNT5A induces release of exosomes containing pro-angiogenic and immunosuppressive factors from malignant melanoma cells

BACKGROUND: Wnt proteins are important for developmental processes and certain diseases. WNT5A is a non-canonical Wnt protein that previously has been shown to play a role in the progression of malignant melanoma. High expression of WNT5A in melanoma tumors correlates to formation of distant metasta...

Descripción completa

Detalles Bibliográficos
Autores principales: Ekström, Elin J, Bergenfelz, Caroline, von Bülow, Verena, Serifler, Filiz, Carlemalm, Eric, Jönsson, Göran, Andersson, Tommy, Leandersson, Karin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4022450/
https://www.ncbi.nlm.nih.gov/pubmed/24766647
http://dx.doi.org/10.1186/1476-4598-13-88
_version_ 1782316410449428480
author Ekström, Elin J
Bergenfelz, Caroline
von Bülow, Verena
Serifler, Filiz
Carlemalm, Eric
Jönsson, Göran
Andersson, Tommy
Leandersson, Karin
author_facet Ekström, Elin J
Bergenfelz, Caroline
von Bülow, Verena
Serifler, Filiz
Carlemalm, Eric
Jönsson, Göran
Andersson, Tommy
Leandersson, Karin
author_sort Ekström, Elin J
collection PubMed
description BACKGROUND: Wnt proteins are important for developmental processes and certain diseases. WNT5A is a non-canonical Wnt protein that previously has been shown to play a role in the progression of malignant melanoma. High expression of WNT5A in melanoma tumors correlates to formation of distant metastasis and poor prognosis. This has partly been described by the findings that WNT5A expression in melanoma cell lines increases migration and invasion. METHODS: Malignant melanoma cell lines were treated with rWNT5A or WNT5A siRNA, and mRNA versus protein levels of soluble mediators were measured using RT-PCR, cytokine bead array and ELISA. The induced signaling pathways were analyzed using inhibitors, Rho-GTPase pull down assays and western blot. Ultracentrifugation and electron microscopy was used to analyze microvesicles. Gene expression microarray data obtained from primary malignant melanomas was used to verify our data. RESULTS: We show that WNT5A signaling induces a Ca(2+)-dependent release of exosomes containing the immunomodulatory and pro-angiogenic proteins IL-6, VEGF and MMP2 in melanoma cells. The process was independent of the transcriptional machinery and depletion of WNT5A reduced the levels of the exosome-derived proteins. The WNT5A induced exosomal secretion was neither affected by Tetanus toxin nor Brefeldin A, but was blocked by the calcium chelator Bapta, inhibited by a dominant negative version of the small Rho-GTPase Cdc42 and was accompanied by cytoskeletal reorganization. Co-cultures of melanoma/endothelial cells showed that depletion of WNT5A in melanoma cells decreased endothelial cell branching, while stimulation of endothelial cells with isolated rWNT5A-induced melanoma exosomes increased endothelial cell branching in vitro. Finally, gene expression data analysis of primary malignant melanomas revealed a correlation between WNT5A expression and the angiogenesis marker ESAM. CONCLUSIONS: These data indicate that WNT5A has a broader function on tumor progression and metastatic spread than previously known; by inducing exosome-release of immunomodulatory and pro-angiogenic factors that enhance the immunosuppressive and angiogenic capacity of the tumors thus rendering them more aggressive and more prone to metastasize.
format Online
Article
Text
id pubmed-4022450
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40224502014-05-16 WNT5A induces release of exosomes containing pro-angiogenic and immunosuppressive factors from malignant melanoma cells Ekström, Elin J Bergenfelz, Caroline von Bülow, Verena Serifler, Filiz Carlemalm, Eric Jönsson, Göran Andersson, Tommy Leandersson, Karin Mol Cancer Research BACKGROUND: Wnt proteins are important for developmental processes and certain diseases. WNT5A is a non-canonical Wnt protein that previously has been shown to play a role in the progression of malignant melanoma. High expression of WNT5A in melanoma tumors correlates to formation of distant metastasis and poor prognosis. This has partly been described by the findings that WNT5A expression in melanoma cell lines increases migration and invasion. METHODS: Malignant melanoma cell lines were treated with rWNT5A or WNT5A siRNA, and mRNA versus protein levels of soluble mediators were measured using RT-PCR, cytokine bead array and ELISA. The induced signaling pathways were analyzed using inhibitors, Rho-GTPase pull down assays and western blot. Ultracentrifugation and electron microscopy was used to analyze microvesicles. Gene expression microarray data obtained from primary malignant melanomas was used to verify our data. RESULTS: We show that WNT5A signaling induces a Ca(2+)-dependent release of exosomes containing the immunomodulatory and pro-angiogenic proteins IL-6, VEGF and MMP2 in melanoma cells. The process was independent of the transcriptional machinery and depletion of WNT5A reduced the levels of the exosome-derived proteins. The WNT5A induced exosomal secretion was neither affected by Tetanus toxin nor Brefeldin A, but was blocked by the calcium chelator Bapta, inhibited by a dominant negative version of the small Rho-GTPase Cdc42 and was accompanied by cytoskeletal reorganization. Co-cultures of melanoma/endothelial cells showed that depletion of WNT5A in melanoma cells decreased endothelial cell branching, while stimulation of endothelial cells with isolated rWNT5A-induced melanoma exosomes increased endothelial cell branching in vitro. Finally, gene expression data analysis of primary malignant melanomas revealed a correlation between WNT5A expression and the angiogenesis marker ESAM. CONCLUSIONS: These data indicate that WNT5A has a broader function on tumor progression and metastatic spread than previously known; by inducing exosome-release of immunomodulatory and pro-angiogenic factors that enhance the immunosuppressive and angiogenic capacity of the tumors thus rendering them more aggressive and more prone to metastasize. BioMed Central 2014-04-26 /pmc/articles/PMC4022450/ /pubmed/24766647 http://dx.doi.org/10.1186/1476-4598-13-88 Text en Copyright © 2014 Ekström et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
spellingShingle Research
Ekström, Elin J
Bergenfelz, Caroline
von Bülow, Verena
Serifler, Filiz
Carlemalm, Eric
Jönsson, Göran
Andersson, Tommy
Leandersson, Karin
WNT5A induces release of exosomes containing pro-angiogenic and immunosuppressive factors from malignant melanoma cells
title WNT5A induces release of exosomes containing pro-angiogenic and immunosuppressive factors from malignant melanoma cells
title_full WNT5A induces release of exosomes containing pro-angiogenic and immunosuppressive factors from malignant melanoma cells
title_fullStr WNT5A induces release of exosomes containing pro-angiogenic and immunosuppressive factors from malignant melanoma cells
title_full_unstemmed WNT5A induces release of exosomes containing pro-angiogenic and immunosuppressive factors from malignant melanoma cells
title_short WNT5A induces release of exosomes containing pro-angiogenic and immunosuppressive factors from malignant melanoma cells
title_sort wnt5a induces release of exosomes containing pro-angiogenic and immunosuppressive factors from malignant melanoma cells
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4022450/
https://www.ncbi.nlm.nih.gov/pubmed/24766647
http://dx.doi.org/10.1186/1476-4598-13-88
work_keys_str_mv AT ekstromelinj wnt5ainducesreleaseofexosomescontainingproangiogenicandimmunosuppressivefactorsfrommalignantmelanomacells
AT bergenfelzcaroline wnt5ainducesreleaseofexosomescontainingproangiogenicandimmunosuppressivefactorsfrommalignantmelanomacells
AT vonbulowverena wnt5ainducesreleaseofexosomescontainingproangiogenicandimmunosuppressivefactorsfrommalignantmelanomacells
AT seriflerfiliz wnt5ainducesreleaseofexosomescontainingproangiogenicandimmunosuppressivefactorsfrommalignantmelanomacells
AT carlemalmeric wnt5ainducesreleaseofexosomescontainingproangiogenicandimmunosuppressivefactorsfrommalignantmelanomacells
AT jonssongoran wnt5ainducesreleaseofexosomescontainingproangiogenicandimmunosuppressivefactorsfrommalignantmelanomacells
AT anderssontommy wnt5ainducesreleaseofexosomescontainingproangiogenicandimmunosuppressivefactorsfrommalignantmelanomacells
AT leanderssonkarin wnt5ainducesreleaseofexosomescontainingproangiogenicandimmunosuppressivefactorsfrommalignantmelanomacells